Connections Vectura Group

VEC

GB00BKM2MW97

Market Closed - London S.E. 11:35:22 2021-10-18 EDT			5-day change	1st Jan Change
164.80 ^GBX	-.--%		-.--%	-

25-10-30	Liquidia Technologies, Inc. Enters into an Exclusive Licensing Agreement with Vectura Limited	CI
24-09-16	Molex Asia Holdings Ltd. signed an agreement to acquire Vectura Group plc from Vectura Fertin Pharma, Inc. for £300 million.	CI

12

Listed companies

4

Private companies

62

Insiders

Relation chart of related listed companies: Vectura Group

Active Relations

Past Relations

Related listed companies: Vectura Group

ANI PHARMACEUTICALS, INC.

Jeanne A. Thoma

ICON PUBLIC LIMITED COMPANY

Anne Michelle Whitaker

DAVIDE CAMPARI-MILANO N.V.

Emmanuel Babeau

OXFORD INSTRUMENTS PLC

Paul Fry

ADVANCED MEDICAL SOLUTIONS GROUP PLC

Juliet Thompson

BASILEA PHARMACEUTICA AG

Thomas Werner

AVACTA GROUP PLC

Paul Fry

PHILIP MORRIS INTERNATIONAL, INC.

ARECOR THERAPEUTICS PLC

Andrew Richards

EDX MEDICAL GROUP PLC

Christopher Evans

Active Relations

Past Relations

Relationship chart for related private companies: Vectura Group

Active Relations

Past Relations

Related private companies: Vectura Group

Pharmathen SA

Pharmaceuticals: Major

Jeanne A. Thoma

Thomas Werner

Endomagnetics Ltd.

Packaged Software

Peter Stephen Keen

Quentin Harmer

Vectura Group Services Ltd.

Miscellaneous Commercial Services

Paul Fry

John Murphy

Imutex Ltd.

Biotechnology

Trevor Phillips

Timothy Sharpington

Active Relations

Past Relations

Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Pharmaceuticals: Major	3
Miscellaneous Commercial Services	3
Biotechnology	3
Medical Specialties	2
Packaged Software	1
Medical/Nursing Services	1
Tobacco	1
Electronic Equipment/Instruments	1
Beverages: Alcoholic	1

Countries of related companies

United Kingdom	8
United States	2
Greece	1
Finland	1
France	1
Switzerland	1
Italy	1
Ireland	1

Vectura Group plc is engaged in research, development and commercialization of therapeutic products and drug delivery systems for human use. The Company's products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) - LABA-LAMA; Seebri Breezhaler (EU and RoW) - LAMA; AirFluSal Forspiro (EU and RoW) - ICS-LABA; ADVATE (Global) - Antihaemophilic Factor (Recombinant); Adept (Global) - Icodextrin; Anoro Ellipta (Global) - LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) - ICS-LABA, and Incruse Ellipta (Global) - LAMA. Its product pipeline includes VR588, VR475, VR647, VR942, VR179, VR736, VR096, VR876, VR315, VR506, VR632, Seebri Neohaler and VR465. Its dry powder inhalers (DPI) include GyroHaler, Lever-operated, Open-inhale-close and Unit Dose DPI. Its smart nebuliser delivery systems provide targeted inhalation therapy for applications where precise and targeted delivery of a drug to the lungs is needed. Its smart nebulizer delivery systems include AKITA JET and FOX.

Employees

Sector

More about the company